Union Pharmacist results, Q1 2025
Net profit, assets, equity and cash flow for Q1 2025, against the same period a year earlier, from the published financial statements.
Net profit-277 thousandEGP · −104.9% vs the same period a year earlier
Total assets85.38 millionEGP · +61.5% vs the same period a year earlier
Shareholders' equity69.7 millionEGP · +95.0% vs the same period a year earlier
Operating cash flow-33.63 millionEGP · −1305.0% vs the same period a year earlier
In short
- Union Pharmacist's net profit for Q1 2025 was about -277 thousand EGP, down −104.9% from 5.62 million EGP in Q1 2024.
- Total assets at the end of Q1 2025 were about 85.38 million EGP, and shareholders' equity about 69.7 million EGP.
- Operating cash flow for Q1 2025 was negative at 33.63 million EGP.
Key lines against the same period a year earlier
This periodQ1 2024Change
Net profit-277 thousand5.62 million−104.9%
Gross profit—52.93 million—
Total assets85.38 million52.87 million+61.5%
Total liabilities15.69 million17.13 million−8.4%
Shareholders' equity69.7 million35.74 million+95.0%
Total liabilities and equity85.38 million52.87 million+61.5%
Operating cash flow-33.63 million2.79 million−1305.0%
Investing cash flow34.24 million-871 thousand+4030.5%
Net change in cash603 thousand1.92 million−68.6%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Union Pharmacist's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy